Skip to main content
logo
Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
40.45
-1.50 (-3.58%)
Sep 18, 2026, 4:00 PM EDT - Market closed

Rapport Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
1,9411,446649--
Market Cap Growth
60.02%122.86%---
Enterprise Value
1,515945330--
Last Close Price
40.4530.3417.74--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
4.592.982.12--
P/TBV Ratio
4.592.982.12--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.020.020.010.050.54
Net Debt / Equity Ratio
-1.01-0.99-0.99-1.00-1.06
Net Debt / EBITDA Ratio
2.793.863.703.913.55
Net Debt / FCF Ratio
4.395.444.524.905.39
Quick Ratio
15.3525.7534.8216.7518.74
Current Ratio
15.7226.1735.3417.1418.80
Return on Equity (ROE)
-39.96%-28.22%-35.09%-43.36%-
Return on Assets (ROA)
-25.78%-18.90%-22.07%-24.18%-
Return on Capital Employed (ROCE)
-35.70%-25.40%-27.10%-24.70%-19.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-7.07%-7.71%-12.07%--
FCF Yield
-5.01%-6.09%-10.36%--
Buyback Yield / Dilution
-27.52%-87.74%-1277.25%-93.74%-
SEC Filings: 10-K · 10-Q